3D Printed PEEK Implants for Cranioplasty
Launched by SKANE UNIVERSITY HOSPITAL · Mar 22, 2022
Trial Information
Current as of May 07, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help patients who need artificial skull bones, a procedure known as cranioplasty. The study is using 3D printed implants made from a special plastic called PEEK. Researchers want to see if this new method is safe and if it works well compared to traditional options like using the patient’s own bone or a different material called PMMA. A total of 40 patients will be involved in this study, which is currently active but not recruiting new participants.
To join the trial, patients must be scheduled for a cranioplasty and able to give informed consent, which means they understand what the study is about and agree to participate. However, those with implants larger than 12x12 cm or who cannot give consent will not be eligible. Participants can expect to receive a 3D printed implant during their surgery, and the team will monitor their recovery and any complications that may arise. This study aims to improve the way skull defects are treated and ultimately enhance patient outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Scheduled for cranioplasty
- • Informed consent
- Exclusion Criteria:
- • No informed consent
- • Implant size greater than 12x12 cm
About Skane University Hospital
Skåne University Hospital is a leading academic medical center located in Sweden, renowned for its commitment to advancing healthcare through innovative clinical research and trials. As a key player in the Nordic healthcare landscape, the hospital integrates cutting-edge medical practices with rigorous scientific inquiry, aiming to improve patient outcomes and foster advancements in medical knowledge. With a multidisciplinary approach, Skåne University Hospital collaborates with various stakeholders, including universities and research institutions, to conduct high-quality clinical trials that address critical health challenges and contribute to the development of new treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lund, , Sweden
Patients applied
Trial Officials
Einar Heiberg, MD, PhD
Study Director
Skane University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials